Syntal Capital Partners’s Altus Pharmaceuticals ALTU Stock Holding History

Syntal Capital Partners’s Portfolio ALTU Stock Details ALTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-66,000	Closed	-$1K	–	234
2019 Q3	$1K	Hold	66,000	–	–	﹤0.01%	231
2019 Q2	$1K	Buy	+66,000	New	+$1K	﹤0.01%	258

Syntal Capital Partners's ALTU Position: Q4 2019 in Review

Syntal Capital Partners sold out of Altus Pharmaceuticals (ALTU) in Q4 2019, closing a stake of 66,000 shares — an estimated $1K sold.

Syntal Capital Partners first reported a position in ALTU in Q2 2019 and held it in 2 quarters. The position peaked at $1K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALTU as of Q4 2019.

Syntal Capital Partners reported no remaining Altus Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Syntal Capital Partners sold 66,000 Altus Pharmaceuticals shares in Q4 2019, an estimated $1K.
Syntal Capital Partners first reported a position in Altus Pharmaceuticals in Q2 2019 and held it in 2 quarters.
Syntal Capital Partners's Altus Pharmaceuticals position peaked at $1K in Q3 2019.
0 funds tracked by Wall St. Rank held Altus Pharmaceuticals as of Q4 2019.

Based on Syntal Capital Partners's 13F filing for Q4 2019, filed 10 Feb 2020.